Muscarinic acetylcholine receptor antagonists

Details for Australian Patent Application No. 2007203078 (hide)

Owner Glaxo Group Limited

Inventors Busch-Petersen, Jakob; Yan, Hongxing; Wan, Zehong; Palovich, Michael R.; Zhu, Chongjie

Agent Davies Collison Cave

Pub. Number AU-B-2007203078

Parent 2004281724

Filing date 2 July 2007

Wipo publication date 19 July 2007

Acceptance publication date 22 July 2010

International Classifications

C07D 451/02 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

Event Publications

19 July 2007 Application Open to Public Inspection

  Published as AU-B-2007203078

19 July 2007 Complete Application Filed

22 July 2010 Application Accepted

  Published as AU-B-2007203078

18 November 2010 Standard Patent Sealed

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007203079-N- (3-methoxy-5-methylpyrazin-2-yl)-2-(4- [1,3,4-oxadiazol-2-yl]phenyl)pyridine-3sulphonamide as an anticancer agent

2007203077-Muscarinic acetylcholine receptor antagonists